FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes new cyclic derivatives of urea of the general formula (I)
where values W, R4,R4Δ,R5,R6,R7,R7Δ and n are given in p. 1 of the invention claims. Synthesized compounds can be used as inhibitors of retroviral protease activity. Invention describes a pharmaceutical composition based on compounds of the formula (I) and a method of inhibition of retrovirus growth using compounds of the formula (I). EFFECT: enhanced inhibitory activity of compounds. 20 cl, 2 tbl, 22 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ISOXAZOLINES AND ISOXAZOLES, METHOD OF INHIBITION OF PLATELET AGGREGATION, PHARMACEUTICAL COMPOSITION INHIBITING PLATELET AGGREGATION | 1994 |
|
RU2149871C1 |
| ANTHRAPYRAZOLONE DERIVATIVES, METHODS OF THEIR SYNTHESIS AND METHODS OF SYNTHESIS OF ANTHRAPYRAZOLONES FROM THEIR SHOWING ANTITUMOR ACTIVITY | 1994 |
|
RU2142456C1 |
| 1-N-ALKYL-N-ARYLPYRIMODINEAMINES, METHOD OF PATIENT TREATMENT, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2153494C2 |
| POLYCYCLIC COMPOUNDS, THEIR DERIVATIVES, PHARMACEUTICAL PREPARATIONS AS ENHANCERS AND METHOD OF TREATMENT OF INTELLECTUAL ACTIVITY DISORDER | 1994 |
|
RU2152944C1 |
| CYCLIC PEPTIDES, RADIOPHARMACEUTICAL PREPARATION, AND RADIOACTIVELY LABELED CYCLIC PEPTIDES | 1994 |
|
RU2145608C1 |
| METHOD OF SYNTHESIS OF IMIDAZOLES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALT | 1989 |
|
RU2028293C1 |
| CYCLIC PEPTIDES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2096415C1 |
| PYRAZOLE COMPOUNDS HAVING A THERAPEUTIC EFFECT ON MULTIPLE MYELOMA | 2011 |
|
RU2583430C2 |
| NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES OF FLUORENE | 1992 |
|
RU2051151C1 |
| CARBOCYCLIC AND HETEROCYCLIC CONDENSED COMPOUNDS OF QUINOLINE CARBOXYLIC ACID SUITED AS IMMUNODEPRESSANTS | 1994 |
|
RU2133740C1 |
Authors
Dates
1999-06-10—Published
1992-10-13—Filed